Comparative tumor RNA sequencing analysis for difficult-to-treat pediatric and young adult patients with cancer
Importance Pediatric cancers are epigenetic diseases; therefore, considering tumor gene
expression information is necessary for a complete understanding of the tumorigenic processes…
expression information is necessary for a complete understanding of the tumorigenic processes…
[PDF][PDF] Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design
Accelerating cures for children with cancer remains an immediate challenge as a result of
extensive oncogenic heterogeneity between and within histologies, distinct molecular …
extensive oncogenic heterogeneity between and within histologies, distinct molecular …
Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7
Purpose Somatic variants in tumor necrosis factor receptor–associated factor 7 (TRAF7) cause
meningioma, while germline variants have recently been identified in seven patients with …
meningioma, while germline variants have recently been identified in seven patients with …
TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma
…, BKN Seynnaeve, JM Kirkwood, OM Vaske… - Science, 2022 - science.org
Overcoming replicative senescence is an essential step during oncogenesis, and the
reactivation of TERT through promoter mutations is a common mechanism. TERT promoter …
reactivation of TERT through promoter mutations is a common mechanism. TERT promoter …
[PDF][PDF] Integrated proteogenomic characterization across major histological types of pediatric brain cancer
…, N Gupta, NJ Edwards, NA Vitanza, OM Vaske… - Cell, 2020 - cell.com
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
[HTML][HTML] The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science
…, HB Lindsay, AG Stucklin, N Gerber, OM Vaske… - Neoplasia, 2023 - Elsevier
Pediatric brain tumors are the leading cause of cancer-related death in children in the United
States and contribute a disproportionate number of potential years of life lost compared to …
States and contribute a disproportionate number of potential years of life lost compared to …
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome
…, F Lieberman, NM Amankulor, SG Wendell, OM Vaske… - Nature cancer, 2022 - nature.com
Diffuse midline gliomas (DMGs) bearing driver mutations of histone 3 lysine 27 (H3K27M)
are incurable brain tumors with unique epigenomes. Here, we generated a syngeneic …
are incurable brain tumors with unique epigenomes. Here, we generated a syngeneic …
[HTML][HTML] Barriers to accessing public cancer genomic data
Although increasingly recognized as critical to genomic research, genomic data sharing is
hindered by an absence of standards regarding timing, patient privacy, use agreement …
hindered by an absence of standards regarding timing, patient privacy, use agreement …
[HTML][HTML] A functional precision medicine pipeline combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for …
…, M Gokden, S Salama, CP Wardell, RL Eoff, OM Vaske… - Cells, 2021 - mdpi.com
Li Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome caused by
germline mutations in TP53. TP53 is the most common mutated gene in human cancer, …
germline mutations in TP53. TP53 is the most common mutated gene in human cancer, …
[HTML][HTML] Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors
…, D Haussler, SR Salama, OM Vaske - Communications …, 2022 - nature.com
Cancer cell lines have been widely used for decades to study biological processes driving
cancer development, and to identify biomarkers of response to therapeutic agents. Advances …
cancer development, and to identify biomarkers of response to therapeutic agents. Advances …